HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$20.16
Day range
$20.11 - $22.44
Year range
$6.88 - $37.27
Market cap
337.34M USD
Avg Volume
203.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.89M | 11.76% |
Net income | -24.74M | -26.76% |
Net profit margin | — | — |
Earnings per share | -1.13 | — |
EBITDA | -26.62M | -28.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 269.01M | -13.89% |
Total assets | 288.60M | -14.04% |
Total liabilities | 23.72M | -6.46% |
Total equity | 264.89M | — |
Shares outstanding | 15.57M | — |
Price to book | 1.18 | — |
Return on assets | -23.77% | — |
Return on capital | -24.89% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -24.74M | -26.76% |
Cash from operations | -17.43M | 0.38% |
Cash from investing | 29.61M | 128.85% |
Cash from financing | 20.66M | -89.13% |
Net change in cash | 32.84M | -53.05% |
Free cash flow | -9.02M | 8.72% |
About
Founded
2018
Website
Employees
131
